Drug Discovery

Toronto, Ontario, Canada, September 16, 2026 Thryv Therapeutics has announced the publication of new research in JACC: Heart Failure...

New York, New York, September 15, 2026 Acurx Pharmaceuticals has announced the presentation of new preclinical microbiology data for...

Cambridge, Massachusetts, September 15, 2026 QurCan Therapeutics has entered into a strategic research and collaboration agreement with Eli Lilly...

COPENHAGEN, Denmark — September 14, 2026 Evaxion A/S announced that it has begun applying its proprietary AI-Immunology™ platform to...

NEW YORK — September 9, 2026 Schrödinger, Inc. announced the formation of Tectora Therapeutics, a new biotechnology company focused...

Shirley, New York, September 3, 2026 American Regent, Inc. has initiated a voluntary nationwide recall of three lots of...

San Francisco, California, September 3, 2026 Thryv Therapeutics Inc., a clinical-stage biopharmaceutical company developing selective SGK1 inhibitors, has entered...

OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...

Boston, Mass. – August 27, 2026 Rectify Pharmaceuticals presented the discovery and characterization of RTY-406, an oral, once-daily investigational...

Tokyo, Japan and Cambridge, UK — August 26, 2026 Nxera Pharma Co., Ltd. announced that its partner Neurocrine Biosciences...